SNY
SanofiCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Bull case: successful late-stage readouts and positive guidance lift sentiment, leading to multiple expansion and ~+20% upside from the anchor amid stable fundamentals.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +7.1.
What can break
Adverse regulatory decisions
Momentum
36
Value
60
Sentiment
70
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $51.64 · Bull $62.00 · Bear $41.31
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2025-10-26 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $56.90
Why
Momentum36 · Δ7d +4.3
Value60 · Δ7d +0.4
Sentiment70 · Δ7d +7.1
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
36
34% active weight
Current posture
7d trendFlat
Δ7d
+4.3
Δ21d
+11.3
Value
60
32% active weight
Current posture
7d trendFlat
Δ7d
+0.4
Δ21d
+0.4
Sentiment
70
33% active weight
Current posture
7d trendImproving
Δ7d
+7.1
Δ21d
+7.7
Why this grade
Composite grade C. Momentum 35.8 / Value 59.8 / Sentiment 69.8
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$104.01B
Beta
0.43
Shares Out
1.22B
P/E (TTM)
16.1
P/S (TTM)
2.35
P/FCF (TTM)
97.54
Rev YoY
-7.0%
EPS YoY
+3.1%
Gross Margin
+72.6%
Op Margin
+18.9%
Net Debt
$10.78B
Current Ratio
1.06
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology